Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 −2518 G/G genotype in CAD patients
- 1 September 2001
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 158 (1), 233-239
- https://doi.org/10.1016/s0021-9150(01)00423-3
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The Role of MCP‐1 in AtherosclerosisThe International Journal of Cell Cloning, 2000
- Association of CCR5 ▵32 with reduced risk of asthmaThe Lancet, 1999
- A Novel Polymorphism in the MCP-1 Gene Regulatory Region That Influences MCP-1 ExpressionBiochemical and Biophysical Research Communications, 1999
- Monocyte Chemoattractant Protein-1 Accelerates Atherosclerosis in Apolipoprotein E-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Genetic Restriction of AIDS Pathogenesis by an SDF-1 Chemokine Gene VariantScience, 1998
- Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease ProgressionScience, 1997
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Chemokine receptors and T cell chemotaxis.The Journal of Experimental Medicine, 1996
- Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective studyPublished by American Medical Association (AMA) ,1996
- Lipoprotein(a): relation to other risk factors and genetic heritability. Results from a Dutch parent-twin studyAtherosclerosis, 1993